Showing results (401-410 of 798) with videos related to
Sort By:
Pageof 80
Medchemcomm|January 9, 2018
Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activitySandeep Sundriyal, Patty B Chen, Alexandra S Lubin, et al.Medchemcomm|March 13, 2018
Phenylethynyl-substituted Heterocycles Inhibit Cyclin D1 and Induce the Expression of Cyclin-dependent Kinase Inhibitor p21Wif1/Cip1 in Colorectal Cancer CellsVitaliy M Sviripa, Liliia M Kril, Wen Zhang, et al.Medchemcomm|December 19, 2017
Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congenersRomain Duroux, Antonella Ciancetta, Philip Mannes, et al.Medchemcomm|December 21, 2018
Synthesis and biological evaluation of 3-(1,3,4-oxadiazol-2-yl)-1,8-naphthyridin-4(1H)-ones as cisplatin sensitizersXueyan Hou, Hao Luo, Mengqi Zhang, et al.Medchemcomm|December 21, 2018
The emerging chemical patterns applied in predicting human toll-like receptor 8 agonistsShuheng Huang, Hu Mei, Duo Zhang, et al.Medchemcomm|August 17, 2016
Design, synthesis and evaluation of novel 19F magnetic resonance sensitive protein tyrosine phosphatase inhibitorsYu Li, Guiquan Xia, Qi Guo, et al.Medchemcomm|August 11, 2015
Synthesis and evaluation of a series of resveratrol analogues as potent anti-cancer agents that target tubulinNikhil R Madadi, Hongliang Zong, Amit Ketkar, et al.Medchemcomm|August 4, 2015
Structure-Based Design, Synthesis by Click Chemistry and in Vivo Activity of Highly Selective A3 Adenosine Receptor AgonistsDilip K Tosh, Silvia Paoletta, Zhoumou Chen, et al.Medchemcomm|December 19, 2015
The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomainsDuncan Hay, Oleg Fedorov, Panagis Filippakopoulos, et al.Medchemcomm|December 23, 2015
Structural biology and chemistry of protein arginine methyltransferasesMatthieu Schapira, Renato Ferreira de FreitasPageof 80